1. Taking Stock of Surgeons’ Integrity and Vitality: Why the “Three A’s” No Longer Tell the Whole Story

   • Lauren Kosinski

   Healthcare Policy and Outcomes Open access 28 October 2009 Pages: 351 - 353

2. K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy

   • Kiran Turaga
   • David Shibata

   Colorectal Cancer Open access 20 November 2009 Pages: 354 - 355

3. Mini-Mesohepatectomy for Colorectal Metastasis Invading the Middle Hepatic Vein at the Hepatocaval Confluence: Educational Video Demonstrating IOUS Use in Modern Hepatic Surgery

   • Masatoshi Makuuchi
   • Hideki Abe

   Hepatobiliary Tumors Open access 01 December 2009 Pages: 356 - 357

4. Why Does No One Want to Perform Lymph Node Dissection Anymore?

   • Kelly M. McMasters

   Melanomas Open access 26 November 2009 Pages: 358 - 361

5. Renal Cell Carcinoma and Prognostic Factors Predictive of Survival

   • M. Sorbellini
   • G. Bratslavsky

   Urologic Oncology Open access 12 November 2009 Pages: 362 - 363

6. A Fire in Our Hearts: Passion and the Art of Surgery

   • S. Eva Singletary

   Healthcare Policy and Outcomes 03 December 2009 Pages: 364 - 370

   

7. Impact of Selection Bias on the Utilization of Adjuvant Therapy for Pancreas Adenocarcinoma

   • Andrew J. Russ
   • Sharon M. Weber
   • Clifford S. Cho

   Healthcare Policy and Outcomes 23 October 2009 Pages: 371 - 376

   

8. National Quality Measures for Breast Centers (NQMBC): A Robust Quality Tool

   • C. S. Kaufman
   • L. Shockney
   • Quality Initiative Committee

   Breast Oncology 16 October 2009 Pages: 377 - 385

   

9. Controversies in Thyroid Pathology: Thyroid Capsule Invasion and Extrathyroidal Extension

   • Ozgur Mete
   • Lorne Rotstein
   • Sylvia L. Asa

   Endocrine Tumors 01 December 2009 Pages: 386 - 391

   

10. The Utility of Metaiodobenzylguanidine Single Photon Emission Computed Tomography/Computed Tomography (MIBG SPECT/CT) for the Diagnosis of Pheochromocytoma

    • Goswin Y. Meyer-Rochow
    • Geoff P. Schembri
    • Stan B. Sidhu

    Endocrine Tumors 01 December 2009 Pages: 392 - 400

    

11. Complete Femoral Nerve Resection with Soft Tissue Sarcoma: Functional Outcomes

    • Kevin B. Jones
    • Peter C. Ferguson
    • Jay S. Wunder

    Bone and Soft Tissue Sarcomas 20 October 2009 Pages: 401 - 406

    

12. Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate

    • Chandrajit P. Raut
    • Qian Wang
    • Monica M. Bertagnolli

    Bone and Soft Tissue Sarcomas 07 November 2009 Pages: 407 - 415

    

13. KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer

    • Garrett M. Nash
    • Mark Gimbel
    • Philip B. Paty

    Gastrointestinal Oncology 08 October 2009 Pages: 416 - 424

    

14. Stage III Colorectal Cancer: Molecular Disparity Between Primary Cancers and Lymph Node Metastases

    • Craig A. Messick
    • James M. Church
    • Matthew F. Kalady

    Colorectal Cancer 03 November 2009 Pages: 425 - 431

15. Impact of Palliative Chemotherapy and Surgery on Management of Stage IV Incurable Colorectal Cancer

    • Renato Costi
    • Davide Di Mauro
    • Vincenzo Violi

    Colorectal Cancer 20 November 2009 Pages: 432 - 440

    

16. Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer

    • Glenda G. Callender
    • Prajnan Das
    • Barry W. Feig

    Gastrointestinal Oncology 22 October 2009 Pages: 441 - 447

    

17. Recurrence After Curative Resection of Early Gastric Cancer

    • Ho Geun Youn
    • Ji Yeong An
    • Sung Kim

    Gastrointestinal Oncology 11 November 2009 Pages: 448 - 454

    

18. Positive Peritoneal Washing Cytology in Multiple Cavities Can Predict Poor Prognosis of Advanced Gastric Cancer Patients

    • Yoichiro Homma
    • Shinichiro Ushida
    • Kazufumi Suzuki

    Gastrointestinal Oncology 22 October 2009 Pages: 455 - 460

    

19. Malignant Ascites Symptom Cluster in Patients Referred for Paracentesis

    • Amna Husain
    • Andrea Bezjak
    • Alexandra Easson

    Gastrointestinal Oncology 29 October 2009 Pages: 461 - 469

    

20. Temporary Placement of Self-Expanding Oesophageal Stents as Bridging for Neo-Adjuvant Therapy

    • Felix B. Langer
    • Sebastian F. Schoppmann
    • Johannes Zacherl

    Gastrointestinal Oncology 27 October 2009 Pages: 470 - 475

    

21. Pneumonectomy After Neoadjuvant Chemotherapy and Radiation for Advanced-Stage Lung Cancer

    • Thomas Ng
    • Ariel E. Birnbaum
    • Thomas A. Dipetrillo

    Thoracic Oncology 14 November 2009 Pages: 476 - 482

    

22. Minimesohepatectomy for Colorectal Liver Metastasis Invading the Middle Hepatic Vein at the Hepatocaval Confluence

    • Guido Torzilli
    • Florin Botea
    • Angela Palmisano

    Hepatobiliary Tumors 23 October 2009 Pages: 483 - 483

23. Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option

    • Akshat Saxena
    • Lourens Bester
    • David L. Morris

    Gastrointestinal Oncology 30 October 2009 Pages: 484 - 491

    

24. Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases

    • Terence C. Chua
    • Akshat Saxena
    • David L. Morris

    Hepatobiliary Tumors 24 October 2009 Pages: 492 - 501

    

25. Preoperative Diabetes Mellitus and Long-Term Survival After Resection of Pancreatic Adenocarcinoma

    • Carrie K. Chu
    • Ashley E. Mazo
    • David A. Kooby

    Pancreatic Tumors 03 November 2009 Pages: 502 - 513

    

26. Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy

    • T. Peter Kingham
    • Katherine S. Panageas
    • Daniel G. Coit

    Melanomas 19 November 2009 Pages: 514 - 520

    

27. Reevaluation of the Locoregional Recurrence Rate in Melanoma Patients With a Positive Sentinel Node Compared to Patients With Palpable Nodal Involvement

    • Hidde J. Veenstra
    • Iris M. C. van der Ploeg
    • Omgo E. Nieweg

    Melanomas 07 November 2009 Pages: 521 - 526

    

28. Evaluation of Clinical and Histomorphological Parameters as Potential Predictors of Occult Metastases in Sentinel Lymph Nodes of Early Squamous Cell Carcinoma of the Oral Cavity

    • Mete Goerkem
    • Julia Braun
    • Sandro J. Stoeckli

    Head and Neck Oncology 16 October 2009 Pages: 527 - 535

    

29. Postoperative Morbidity and Mortality of Head and Neck Cancers in Patients With Liver Cirrhosis Undergoing Surgical Resection Followed by Microsurgical Free Tissue Transfer

    • Huang-Kai Kao
    • Kai-Ping Chang
    • Fu-Chan Wei

    Reconstructive Oncology 11 November 2009 Pages: 536 - 543

30. Prognostic Factors Influencing Long-Term Survival of Patients Undergoing Nephron-Sparing Surgery for Nonmetastatic Renal-Cell Carcinoma (RCC) with Imperative Indications

    • Axel Haferkamp
    • Martin Kurosch
    • Markus Hohenfellner

    Urologic Oncology 01 December 2009 Pages: 544 - 551

    

31. Erratum to: Axillary Recurrence Rate Following Negative Sentinel Node Biopsy for Invasive Breast Cancer: Long-Term Follow-Up

    • John V. Kiluk
    • Quan P. Ly
    • Charles E. Cox

    Erratum 03 December 2009 Pages: 552 - 557

32. What is an Adequate Margin for Breast-Conserving Surgery? Surgeon Attitudes and Correlates

    • Michelle Azu
    • Paul Abrahamse
    • Monica Morrow

    Breast Oncology 22 October 2009 Pages: 558 - 563

33. E2F1 Expression Predicts Outcome in Korean Women Who Undergo Surgery for Breast Carcinoma

    • Mi Jung Kwon
    • Eun Sook Nam
    • Won Jae Lee

    Breast Oncology 20 October 2009 Pages: 564 - 571

    

34. KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases

    • Garrett M. Nash
    • Mark Gimbel
    • Philip B. Paty

    Translational Research and Biomarkers 01 September 2009 Pages: 572 - 578

    

35. Beyond the False Negative Rate: Development of Quality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer

    • May Lynn Quan
    • Bryan J. Wells
    • Anna R. Gagliardi

    Translational Research and Biomarkers 26 August 2009 Pages: 579 - 591

    

36. Inhibition of Autophagy Potentiates Sulforaphane-Induced Apoptosis in Human Colon Cancer Cells

    • Takeshi Nishikawa
    • Nelson H. Tsuno
    • Hirokazu Nagawa

    Translational Research and Biomarkers 15 October 2009 Pages: 592 - 602

    

37. Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma

    • Jeng-Fong Chiou
    • Cheng-Jeng Tai
    • Yu-Jia Chang

    Translational Research and Biomarkers 15 October 2009 Pages: 603 - 612

    

38. Characterizing the HER2/neu Status and Metastatic Potential of Breast Cancer Stem/Progenitor Cells

    • SuEllen J. Pommier
    • Glenda G. Quan
    • Rodney F. Pommier

    Translational Research and Biomarkers 17 October 2009 Pages: 613 - 623

    

39. Enhancing Detection of Circulating Tumor Cells with Activating KRAS Oncogene in Patients with Colorectal Cancer by Weighted Chemiluminescent Membrane Array Method

    • Ming-Je Yang
    • Hua-Hsien Chiu
    • Shiu-Ru Lin

    Translational Research and Biomarkers 24 November 2009 Pages: 624 - 633

    

40. p53 Genotype Predicts Response to Chemotherapy in Patients with Squamous Cell Carcinoma of the Esophagus

    • Makoto Yamasaki
    • Hiroshi Miyata
    • Yuichiro Doki

    Translational Research and Biomarkers 26 November 2009 Pages: 634 - 642

    

41. Adenoviral Oncolytic Suicide Gene Therapy for a Peritoneal Dissemination Model of Gastric Cancer in Mice

    • Yu Imamura
    • Shinji Ishikawa
    • Hideo Baba

    Translational Research and Biomarkers 10 December 2009 Pages: 643 - 652

    

42. Caution in Adding Bevacizumab in the Adjuvant Treatment of Breast Cancer

    • Dimosthenis Ziogas
    • Dimitrios Roukos

    Medical Oncology 04 November 2009 Pages: 653 - 654

43. Continued Exploration of Bevacizumab in Breast Cancer

    • Rita S. Mehta
    • Min-Ying Su

    Breast Oncology Open access 21 November 2009 Pages: 655 - 656

44. A Different Variable to Stratify Risk in Resected Gastric Cancer

    • Esther Uña Cidón

    Gastrointestinal Oncology 31 October 2009 Pages: 657 - 658

45. The Lymph Node Ratio Staging System in Gastric Cancer

    • Da-zhi Xu

    Gastrointestinal Oncology 04 November 2009 Pages: 659 - 659

46. Potential Cost-Effectiveness of US-Guided FNAC in Melanoma Patients as a Primary Procedure and in Follow-Up

    • Alexander C. J. van Akkooi
    • Christiane A. Voit
    • Alexander M. M. Eggermont

    Melanomas Open access 17 November 2009 Pages: 660 - 662

    

47. In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma

    • Rachael L. Morton
    • Kirsten Howard
    • John F. Thompson

    Melanomas 05 December 2009 Pages: 663 - 664